首页 > 最新文献

Pediatric Investigation最新文献

英文 中文
Application of topical gentamicin ointment in the treatment of Nagashima-type palmoplantar keratosis in children with a nonsense mutation. 应用庆大霉素软膏治疗无义突变儿童Nagashima型掌跖角化病。
IF 1.9 4区 医学 Q2 PEDIATRICS Pub Date : 2023-06-28 eCollection Date: 2023-09-01 DOI: 10.1002/ped4.12389
Shan Wang, Zhou Yang, Ying Liu, Huan Zhang, Zongyang Liu, Xiaoling Wang, Ying Li, Haihong Liu, Yonghong Yang, Lin Ma

Importance: Nagashima-type palmoplantar keratosis (NPPK) is a hereditary dermatosis mostly caused by a nonsense mutation in SERPINB7. Despite the increasing interest in readthrough gentamicin treatment of NPPK, clinical evidence for this treatment is limited.

Objective: This study aimed to provide further evidence for the use of topical gentamicin in the treatment of NPPK in children with nonsense mutations.

Methods: We designed a bilaterally controlled study of topical gentamicin ointment. Children diagnosed with NPPK carrying nonsense mutations were enrolled in this study. A 0.1% gentamicin ointment was applied to one hand and an emollient to the other for 3 months. A bilateral comparison of the visual analog scale scores for clinical manifestations and safety was performed.

Results: Ten children with NPPK were included in this study. In comparison with the emollient side, the topical gentamicin side showed significant improvements in hyperkeratosis, erythema, maceration, and desquamation after 1 and 3 months of treatment (P < 0.05). However, hyperhidrosis and odor did not improve significantly. No adverse events were observed during the systemic safety monitoring examinations.

Interpretation: Topical gentamicin ointment showed good safety in the treatment of NPPK with nonsense mutations, indicating that it is a promising therapeutic choice in children with NPPK.

重要性:长岛型掌跖角化病(NPPK)是一种遗传性皮肤病,主要由SERPINB7的无义突变引起。尽管人们对庆大霉素治疗NPPK越来越感兴趣,但这种治疗的临床证据有限。目的:本研究旨在为外用庆大霉素治疗无义突变儿童NPPK提供进一步的证据。方法:我们设计了庆大霉素软膏的双侧对照研究。被诊断为携带无义突变的NPPK的儿童被纳入本研究。一只手涂0.1%庆大霉素软膏,另一只手用润肤剂,持续3个月。对临床表现和安全性的视觉模拟量表评分进行了双边比较。结果:本研究纳入10名NPPK患儿。与润肤剂组相比,庆大霉素组在治疗1个月和3个月后,角化过度、红斑、浸渍和脱屑的情况有显著改善(P 0.05),但多汗和异味的情况没有显著改善。系统安全监测检查期间未观察到不良事件。解释:庆大霉素外用软膏在治疗无义突变的NPPK中显示出良好的安全性,表明它是治疗NPPK儿童的一种有前景的治疗选择。
{"title":"Application of topical gentamicin ointment in the treatment of Nagashima-type palmoplantar keratosis in children with a nonsense mutation.","authors":"Shan Wang, Zhou Yang, Ying Liu, Huan Zhang, Zongyang Liu, Xiaoling Wang, Ying Li, Haihong Liu, Yonghong Yang, Lin Ma","doi":"10.1002/ped4.12389","DOIUrl":"10.1002/ped4.12389","url":null,"abstract":"<p><strong>Importance: </strong>Nagashima-type palmoplantar keratosis (NPPK) is a hereditary dermatosis mostly caused by a nonsense mutation in <i>SERPINB7</i>. Despite the increasing interest in readthrough gentamicin treatment of NPPK, clinical evidence for this treatment is limited.</p><p><strong>Objective: </strong>This study aimed to provide further evidence for the use of topical gentamicin in the treatment of NPPK in children with nonsense mutations.</p><p><strong>Methods: </strong>We designed a bilaterally controlled study of topical gentamicin ointment. Children diagnosed with NPPK carrying nonsense mutations were enrolled in this study. A 0.1% gentamicin ointment was applied to one hand and an emollient to the other for 3 months. A bilateral comparison of the visual analog scale scores for clinical manifestations and safety was performed.</p><p><strong>Results: </strong>Ten children with NPPK were included in this study. In comparison with the emollient side, the topical gentamicin side showed significant improvements in hyperkeratosis, erythema, maceration, and desquamation after 1 and 3 months of treatment (<i>P <</i> 0.05). However, hyperhidrosis and odor did not improve significantly. No adverse events were observed during the systemic safety monitoring examinations.</p><p><strong>Interpretation: </strong>Topical gentamicin ointment showed good safety in the treatment of NPPK with nonsense mutations, indicating that it is a promising therapeutic choice in children with NPPK.</p>","PeriodicalId":19992,"journal":{"name":"Pediatric Investigation","volume":"7 3","pages":"163-167"},"PeriodicalIF":1.9,"publicationDate":"2023-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/db/2d/PED4-7-163.PMC10509405.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41146108","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pityriasis versicolor on the scalp: An unusual distribution of a common disease. 头皮花斑癣:一种常见疾病的不寻常分布。
IF 1.9 4区 医学 Q2 PEDIATRICS Pub Date : 2023-06-26 eCollection Date: 2023-09-01 DOI: 10.1002/ped4.12387
Lijuan Wang, Huan Xing
{"title":"Pityriasis versicolor on the scalp: An unusual distribution of a common disease.","authors":"Lijuan Wang, Huan Xing","doi":"10.1002/ped4.12387","DOIUrl":"10.1002/ped4.12387","url":null,"abstract":"","PeriodicalId":19992,"journal":{"name":"Pediatric Investigation","volume":"7 3","pages":"216-217"},"PeriodicalIF":1.9,"publicationDate":"2023-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/5c/ad/PED4-7-216.PMC10509390.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41145763","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is fat-free mass-based gentamicin dosing regimen preferable than whole-body weight in neonates? 在新生儿中,以去脂体重为基础的庆大霉素给药方案比以全身体重为基础的给药方案更可取吗?
IF 1.9 4区 医学 Q2 PEDIATRICS Pub Date : 2023-06-08 eCollection Date: 2023-06-01 DOI: 10.1002/ped4.12386
Kannan Sridharan, Muna Al Jufairi, Eman Al Ansari, Lulwa Alsadah, Howra Wasel

Importance: Body fluid dynamics and renal maturation status vary during the neonatal period. We hypothesized that differences in peak and trough gentamicin concentrations could be expected.

Objective: To predict the peak and trough gentamicin concentrations in critically ill neonates and to predict the changes in the predicted peak plasma concentrations of gentamicin following fat-free mass dosing.

Methods: Critically ill neonates that received gentamicin and have gentamicin concentration measured were recruited. Fat mass was estimated using skinfold thicknesses. Changes in the peak plasma concentrations (Cmax) using whole-body weight (estimated using the current dosing regimen) and predicted concentrations following the fat-free mass-based dosing were the outcome measures.

Results: Eighty-nine critically ill neonates were recruited. Sub-therapeutic Cmax was estimated using the current dosing regimen in 32.6%, and 22.5% neonates following the first and second doses of gentamicin. Preterm neonates had significantly higher fat mass compared to term neonates. All except one had Cmax above 12 μg/ml after the first dose and all had after the second gentamicin dose following the predicted fat-free mass-based gentamicin dosing. The recommended doses are as follows: extreme preterm: 7.95 mg/kg every 48 h; very preterm: 7.30 mg/kg every 36-48 h; late preterm: 5.90 mg/kg every 36-48 h; and term neonates at 5.10 mg/kg every 24 h.

Interpretation: Fat-free mass dosing may be considered for obtaining optimal therapeutic effects in the neonatal population.

重要性:新生儿期的体液动力学和肾脏成熟状态各不相同。我们假设庆大霉素的峰值和谷值浓度可能会出现差异:目的:预测重症新生儿庆大霉素的峰值和谷值浓度,并预测庆大霉素的预测血浆峰值浓度在无脂肪量给药后的变化:方法:招募接受过庆大霉素治疗并测量过庆大霉素浓度的重症新生儿。用皮褶厚度估算脂肪量。结果:89 名重症新生儿接受了庆大霉素治疗,并测量了庆大霉素的浓度:结果:共招募了 89 名重症新生儿。根据目前的给药方案估计,32.6%的新生儿和22.5%的新生儿在服用第一和第二剂量庆大霉素后会出现治疗浓度不足的情况。早产新生儿的脂肪含量明显高于足月新生儿。按照预测的去脂体重庆大霉素剂量,除一名新生儿外,所有新生儿在服用第一剂庆大霉素后的 Cmax 均超过 12 μg/ml,而在服用第二剂庆大霉素后,所有新生儿的 Cmax 均超过 12 μg/ml。推荐剂量如下:极早产儿:7.95 毫克/千克,每 48 小时一次;极早产儿:7.30 毫克/千克,每 36-48 小时一次;晚期早产儿:5.90 毫克/千克,每 36-48 小时一次;足月新生儿:5.10 毫克/千克,每 24 小时一次:释义:为在新生儿中获得最佳治疗效果,可考虑无脂质量剂量。
{"title":"Is fat-free mass-based gentamicin dosing regimen preferable than whole-body weight in neonates?","authors":"Kannan Sridharan, Muna Al Jufairi, Eman Al Ansari, Lulwa Alsadah, Howra Wasel","doi":"10.1002/ped4.12386","DOIUrl":"10.1002/ped4.12386","url":null,"abstract":"<p><strong>Importance: </strong>Body fluid dynamics and renal maturation status vary during the neonatal period. We hypothesized that differences in peak and trough gentamicin concentrations could be expected.</p><p><strong>Objective: </strong>To predict the peak and trough gentamicin concentrations in critically ill neonates and to predict the changes in the predicted peak plasma concentrations of gentamicin following fat-free mass dosing.</p><p><strong>Methods: </strong>Critically ill neonates that received gentamicin and have gentamicin concentration measured were recruited. Fat mass was estimated using skinfold thicknesses. Changes in the peak plasma concentrations (C<sub>max</sub>) using whole-body weight (estimated using the current dosing regimen) and predicted concentrations following the fat-free mass-based dosing were the outcome measures.</p><p><strong>Results: </strong>Eighty-nine critically ill neonates were recruited. Sub-therapeutic C<sub>max</sub> was estimated using the current dosing regimen in 32.6%, and 22.5% neonates following the first and second doses of gentamicin. Preterm neonates had significantly higher fat mass compared to term neonates. All except one had C<sub>max</sub> above 12 μg/ml after the first dose and all had after the second gentamicin dose following the predicted fat-free mass-based gentamicin dosing. The recommended doses are as follows: extreme preterm: 7.95 mg/kg every 48 h; very preterm: 7.30 mg/kg every 36-48 h; late preterm: 5.90 mg/kg every 36-48 h; and term neonates at 5.10 mg/kg every 24 h.</p><p><strong>Interpretation: </strong>Fat-free mass dosing may be considered for obtaining optimal therapeutic effects in the neonatal population.</p>","PeriodicalId":19992,"journal":{"name":"Pediatric Investigation","volume":"7 2","pages":"86-94"},"PeriodicalIF":1.9,"publicationDate":"2023-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f6/46/PED4-7-86.PMC10262884.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10029859","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical characteristics and prognosis of 69 cases of neonatal appendicitis. 69 例新生儿阑尾炎的临床特征和预后。
IF 1.9 4区 医学 Q2 PEDIATRICS Pub Date : 2023-06-07 eCollection Date: 2023-06-01 DOI: 10.1002/ped4.12384
Yong Zhao, Caihan Tang, Jinshi Huang, Junmin Liao, Yichao Gu, Kaiyun Hua, Yanan Zhang, Yongwei Chen, Shuangshuang Li

Importance: Neonatal appendicitis (NA) is a rare and potentially fatal neonatal disease. However, misdiagnosis is common owing to atypical clinical manifestations and non-specific laboratory tests.

Objective: The aim of this study was to summarize the clinical characteristics, treatments, and prognoses of infants with NA.

Methods: This retrospective analysis included 69 patients diagnosed with NA admitted to Beijing Children's Hospital between 1980 and 2019. The patients were divided into surgical and non-surgical groups based on whether surgery was performed. Their clinical characteristics were analyzed using the chi-square test, t-test, or the Mann-Whitney U test.

Results: The study included 47 males and 22 females with NA. The primary symptoms were abdominal distension (n = 36, 52.2%), fever (n = 19, 27.5%), refusal to feed or decreased feeding (n = 16, 23.2%), and vomiting (n = 15, 21.7%). Sixty-five patients underwent abdominal ultrasound examinations; 43 had definite appendiceal abnormalities, 10 had right lower abdominal adhesive masses, and 14 had neonatal enterocolitis manifestations. Twenty-nine and 40 patients were in the surgical and non-surgical groups, respectively. No statistically significant differences were observed between the groups regarding sex, age at onset, birth weight, admission weight, or hospitalization time. However, parenteral nutrition was prolonged in the surgical group (P = 0.001). Additionally, two patients (2.9%) died.

Interpretation: NA is a rare neonatal disease with atypical clinical manifestations. Abdominal ultrasonography may aid in the diagnosis. Similarly, appropriate treatment can improve the prognosis.

重要性:新生儿阑尾炎(NA)是一种罕见且可能致命的新生儿疾病。然而,由于不典型的临床表现和非特异性实验室检查,误诊很常见:本研究旨在总结NA婴儿的临床特征、治疗方法和预后:这项回顾性分析纳入了1980年至2019年期间北京儿童医院收治的69名确诊为NA的患者。根据是否进行手术将患者分为手术组和非手术组。他们的临床特征采用卡方检验、t检验或曼-惠特尼U检验进行分析:研究包括 47 名男性和 22 名女性 NA 患者。主要症状为腹胀(36 例,52.2%)、发热(19 例,27.5%)、拒食或进食减少(16 例,23.2%)和呕吐(15 例,21.7%)。65名患者接受了腹部超声波检查,其中43人有明确的阑尾异常,10人有右下腹粘连肿块,14人有新生儿肠炎表现。手术组和非手术组分别有 29 名和 40 名患者。在性别、发病年龄、出生体重、入院体重或住院时间方面,两组之间没有发现明显的统计学差异。不过,手术组的肠外营养时间更长(P = 0.001)。此外,有两名患者(2.9%)死亡:NA是一种罕见的新生儿疾病,临床表现不典型。腹部超声波检查有助于诊断。同样,适当的治疗可改善预后。
{"title":"Clinical characteristics and prognosis of 69 cases of neonatal appendicitis.","authors":"Yong Zhao, Caihan Tang, Jinshi Huang, Junmin Liao, Yichao Gu, Kaiyun Hua, Yanan Zhang, Yongwei Chen, Shuangshuang Li","doi":"10.1002/ped4.12384","DOIUrl":"10.1002/ped4.12384","url":null,"abstract":"<p><strong>Importance: </strong>Neonatal appendicitis (NA) is a rare and potentially fatal neonatal disease. However, misdiagnosis is common owing to atypical clinical manifestations and non-specific laboratory tests.</p><p><strong>Objective: </strong>The aim of this study was to summarize the clinical characteristics, treatments, and prognoses of infants with NA.</p><p><strong>Methods: </strong>This retrospective analysis included 69 patients diagnosed with NA admitted to Beijing Children's Hospital between 1980 and 2019. The patients were divided into surgical and non-surgical groups based on whether surgery was performed. Their clinical characteristics were analyzed using the chi-square test, <i>t</i>-test, or the Mann-Whitney <i>U</i> test.</p><p><strong>Results: </strong>The study included 47 males and 22 females with NA. The primary symptoms were abdominal distension (<i>n</i> = 36, 52.2%), fever (<i>n</i> = 19, 27.5%), refusal to feed or decreased feeding (<i>n</i> = 16, 23.2%), and vomiting (<i>n</i> = 15, 21.7%). Sixty-five patients underwent abdominal ultrasound examinations; 43 had definite appendiceal abnormalities, 10 had right lower abdominal adhesive masses, and 14 had neonatal enterocolitis manifestations. Twenty-nine and 40 patients were in the surgical and non-surgical groups, respectively. No statistically significant differences were observed between the groups regarding sex, age at onset, birth weight, admission weight, or hospitalization time. However, parenteral nutrition was prolonged in the surgical group (<i>P</i> = 0.001). Additionally, two patients (2.9%) died.</p><p><strong>Interpretation: </strong>NA is a rare neonatal disease with atypical clinical manifestations. Abdominal ultrasonography may aid in the diagnosis. Similarly, appropriate treatment can improve the prognosis.</p>","PeriodicalId":19992,"journal":{"name":"Pediatric Investigation","volume":"7 2","pages":"95-101"},"PeriodicalIF":1.9,"publicationDate":"2023-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/46/fd/PED4-7-95.PMC10262871.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10029866","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A novel pathogenic variant of CEP164 in an infant with Senior-Loken syndrome. 一名患有高龄-洛肯综合征的婴儿体内的 CEP164 新型致病变体。
IF 1.9 4区 医学 Q2 PEDIATRICS Pub Date : 2023-06-06 eCollection Date: 2023-06-01 DOI: 10.1002/ped4.12385
Lili Liu, Yunyu Zhou, Yue Liu, Jiaojiao Ding, Yan Xie, Ningdong Li
{"title":"A novel pathogenic variant of <i>CEP164</i> in an infant with Senior-Loken syndrome.","authors":"Lili Liu, Yunyu Zhou, Yue Liu, Jiaojiao Ding, Yan Xie, Ningdong Li","doi":"10.1002/ped4.12385","DOIUrl":"10.1002/ped4.12385","url":null,"abstract":"","PeriodicalId":19992,"journal":{"name":"Pediatric Investigation","volume":"7 2","pages":"140-143"},"PeriodicalIF":1.9,"publicationDate":"2023-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/4e/6b/PED4-7-140.PMC10262869.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9647641","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Infantile hemangiomas screening modalities for primary care physicians. 初级保健医生的婴儿血管瘤筛查模式。
IF 1.9 4区 医学 Q2 PEDIATRICS Pub Date : 2023-05-21 eCollection Date: 2023-09-01 DOI: 10.1002/ped4.12383
Stylianos Roupakias, Eirini Kostopoulou, Despoina Gkentzi, Sotirios Fouzas, Xenophon Sinopidis

Infantile hemangiomas are the most common benign vascular tumors in children. They present a characteristic natural history of spontaneous involution after a phase of initial proliferation. A small but significant minority demonstrates incomplete regression or complications and requires prompt intervention. Prediction of the evolution of infantile hemangiomas is challenging because of their morphological and behavioral heterogeneity. The decision between referral for treatment and observation is sometimes difficult, especially among non-expert physicians, with the risk of missing the period for optimizing outcomes in case of delayed intervention. The aim of this review is to update our knowledge, especially of the primary care providers, regarding the ongoing difficulties of the early clinical evaluation of infantile hemangiomas, and to outline the importance of current practical scoring tools for the identification of the lesions which require expert consultation and referral.

婴儿血管瘤是儿童最常见的良性血管肿瘤。它们呈现出在最初增殖阶段后自发退化的特征性自然史。少数患者出现不完全消退或并发症,需要及时干预。由于其形态和行为的异质性,预测婴儿血管瘤的演变具有挑战性。有时很难在转诊治疗和观察之间做出决定,尤其是在非专家医生中,如果干预延迟,可能会错过优化结果的时间。本综述的目的是更新我们的知识,特别是初级保健提供者的知识,了解婴儿血管瘤早期临床评估的持续困难,并概述当前实用评分工具对识别需要专家咨询和转诊的病变的重要性。
{"title":"Infantile hemangiomas screening modalities for primary care physicians.","authors":"Stylianos Roupakias, Eirini Kostopoulou, Despoina Gkentzi, Sotirios Fouzas, Xenophon Sinopidis","doi":"10.1002/ped4.12383","DOIUrl":"10.1002/ped4.12383","url":null,"abstract":"<p><p>Infantile hemangiomas are the most common benign vascular tumors in children. They present a characteristic natural history of spontaneous involution after a phase of initial proliferation. A small but significant minority demonstrates incomplete regression or complications and requires prompt intervention. Prediction of the evolution of infantile hemangiomas is challenging because of their morphological and behavioral heterogeneity. The decision between referral for treatment and observation is sometimes difficult, especially among non-expert physicians, with the risk of missing the period for optimizing outcomes in case of delayed intervention. The aim of this review is to update our knowledge, especially of the primary care providers, regarding the ongoing difficulties of the early clinical evaluation of infantile hemangiomas, and to outline the importance of current practical scoring tools for the identification of the lesions which require expert consultation and referral.</p>","PeriodicalId":19992,"journal":{"name":"Pediatric Investigation","volume":"7 3","pages":"199-205"},"PeriodicalIF":1.9,"publicationDate":"2023-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/dc/cc/PED4-7-199.PMC10509409.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41137561","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nirsevimab brings breakthrough in the prevention of respiratory syncytial virus infection in infants - Importance of design. Nirsevimab 为预防婴儿呼吸道合胞病毒感染带来突破 - 设计的重要性。
IF 1.9 4区 医学 Q2 PEDIATRICS Pub Date : 2023-05-10 eCollection Date: 2023-06-01 DOI: 10.1002/ped4.12377
Getu Zhaori
{"title":"Nirsevimab brings breakthrough in the prevention of respiratory syncytial virus infection in infants - Importance of design.","authors":"Getu Zhaori","doi":"10.1002/ped4.12377","DOIUrl":"10.1002/ped4.12377","url":null,"abstract":"","PeriodicalId":19992,"journal":{"name":"Pediatric Investigation","volume":"7 2","pages":"144-146"},"PeriodicalIF":1.9,"publicationDate":"2023-05-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/49/14/PED4-7-144.PMC10262870.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9656035","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A new column in this journal - Forum on Clinical Investigation. 本刊新设专栏--"临床研究论坛"。
IF 1.9 4区 医学 Q2 PEDIATRICS Pub Date : 2023-05-09 eCollection Date: 2023-06-01 DOI: 10.1002/ped4.12378
Getu Zhaori
{"title":"A new column in this journal - Forum on Clinical Investigation.","authors":"Getu Zhaori","doi":"10.1002/ped4.12378","DOIUrl":"10.1002/ped4.12378","url":null,"abstract":"","PeriodicalId":19992,"journal":{"name":"Pediatric Investigation","volume":"7 2","pages":"147-149"},"PeriodicalIF":1.9,"publicationDate":"2023-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/44/58/PED4-7-147.PMC10262868.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9656032","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effect of activity and face masks on exhaled particles in children. 活动和口罩对儿童呼出颗粒物的影响。
IF 1.9 4区 医学 Q2 PEDIATRICS Pub Date : 2023-05-03 eCollection Date: 2023-06-01 DOI: 10.1002/ped4.12376
Peter P Moschovis, Jesiel Lombay, Jennifer Rooney, Sara R Schenkel, Dilpreet Singh, Shawheen J Rezaei, Nora Salo, Amanda Gong, Lael M Yonker, Jhill Shah, Douglas Hayden, Patricia L Hibberd, Philip Demokritou, T Bernard Kinane

Importance: Despite the high burden of respiratory infections among children, the production of exhaled particles during common activities and the efficacy of face masks in children have not been sufficiently studied.

Objective: To determine the effect of type of activity and mask usage on exhaled particle production in children.

Methods: Healthy children were asked to perform activities that ranged in intensity (breathing quietly, speaking, singing, coughing, and sneezing) while wearing no mask, a cloth mask, or a surgical mask. The concentration and size of exhaled particles were assessed during each activity.

Results: Twenty-three children were enrolled in the study. Average exhaled particle concentration increased by intensity of activity, with the lowest particle concentration during tidal breathing (1.285 particles/cm3 [95% CI 0.943, 1.627]) and highest particle concentration during sneezing (5.183 particles/cm3 [95% CI 1.911, 8.455]). High-intensity activities were associated with an increase primarily in the respirable size (≤ 5 µm) particle fraction. Surgical and cloth masks were associated with lower average particle concentration compared to no mask (P = 0.026 for sneezing). Surgical masks outperformed cloth masks across all activities, especially within the respirable size fraction. In a multivariable linear regression model, we observed significant effect modification of activity by age and by mask type.

Interpretation: Similar to adults, children produce exhaled particles that vary in size and concentration across a range of activities. Production of respirable size fraction particles (≤ 5 µm), the dominant mode of transmission of many respiratory viruses, increases significantly with coughing and sneezing and is most effectively reduced by wearing surgical face masks.

重要性:尽管儿童的呼吸道感染负担很高,但在日常活动中呼出颗粒物的产生以及口罩对儿童的疗效尚未得到充分研究。目的:确定活动类型和口罩使用对儿童呼出颗粒物产生的影响。方法:健康儿童被要求在不戴口罩、布口罩或外科口罩的情况下进行不同强度的活动(安静呼吸、说话、唱歌、咳嗽和打喷嚏)。在每次活动期间评估呼出颗粒的浓度和大小。结果:23名儿童参与了这项研究。平均呼出颗粒浓度随着活动强度的增加而增加,潮式呼吸时颗粒物浓度最低(1.285个颗粒物/cm3[95%CI 0.943,1.627]),打喷嚏时颗粒物含量最高(5.183个颗粒物g/cm3[95%CI 1.911,8.455])。高强度活动主要与可呼吸尺寸(≤5µm)颗粒物分数的增加有关。与不戴口罩相比,外科口罩和布口罩的平均颗粒物浓度较低(打喷嚏P=0.026)。外科口罩在所有活动中都优于布口罩,尤其是在可呼吸尺寸范围内。在多变量线性回归模型中,我们观察到年龄和口罩类型对活动的显著影响。解释:与成年人类似,儿童在一系列活动中产生的呼出颗粒大小和浓度各不相同。可吸入颗粒物(≤5µm)是许多呼吸道病毒的主要传播方式,其产生量随着咳嗽和打喷嚏而显著增加,佩戴外科口罩最有效地减少了这种产生量。
{"title":"The effect of activity and face masks on exhaled particles in children.","authors":"Peter P Moschovis, Jesiel Lombay, Jennifer Rooney, Sara R Schenkel, Dilpreet Singh, Shawheen J Rezaei, Nora Salo, Amanda Gong, Lael M Yonker, Jhill Shah, Douglas Hayden, Patricia L Hibberd, Philip Demokritou, T Bernard Kinane","doi":"10.1002/ped4.12376","DOIUrl":"10.1002/ped4.12376","url":null,"abstract":"<p><strong>Importance: </strong>Despite the high burden of respiratory infections among children, the production of exhaled particles during common activities and the efficacy of face masks in children have not been sufficiently studied.</p><p><strong>Objective: </strong>To determine the effect of type of activity and mask usage on exhaled particle production in children.</p><p><strong>Methods: </strong>Healthy children were asked to perform activities that ranged in intensity (breathing quietly, speaking, singing, coughing, and sneezing) while wearing no mask, a cloth mask, or a surgical mask. The concentration and size of exhaled particles were assessed during each activity.</p><p><strong>Results: </strong>Twenty-three children were enrolled in the study. Average exhaled particle concentration increased by intensity of activity, with the lowest particle concentration during tidal breathing (1.285 particles/cm<sup>3</sup> [95% CI 0.943, 1.627]) and highest particle concentration during sneezing (5.183 particles/cm<sup>3</sup> [95% CI 1.911, 8.455]). High-intensity activities were associated with an increase primarily in the respirable size (≤ 5 µm) particle fraction. Surgical and cloth masks were associated with lower average particle concentration compared to no mask (<i>P</i> = 0.026 for sneezing). Surgical masks outperformed cloth masks across all activities, especially within the respirable size fraction. In a multivariable linear regression model, we observed significant effect modification of activity by age and by mask type.</p><p><strong>Interpretation: </strong>Similar to adults, children produce exhaled particles that vary in size and concentration across a range of activities. Production of respirable size fraction particles (≤ 5 µm), the dominant mode of transmission of many respiratory viruses, increases significantly with coughing and sneezing and is most effectively reduced by wearing surgical face masks.</p>","PeriodicalId":19992,"journal":{"name":"Pediatric Investigation","volume":"7 2","pages":"75-85"},"PeriodicalIF":1.9,"publicationDate":"2023-05-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/26/5e/PED4-7-75.PMC10262878.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10471810","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A great pediatrician and scholar devoting his whole life to pediatric infectious and digestive diseases—In memoriam of Professor Yongsui Dong 毕生致力于小儿传染病与消化道疾病研究的伟大儿科医生、学者——纪念董永绥教授
IF 2.2 4区 医学 Q2 PEDIATRICS Pub Date : 2023-04-18 DOI: 10.1002/ped4.12373
Xinglou Liu, S. Shu, S. Gong, Xiaoping Luo, F. Fang
Professor Dong graduated from the Medical College of Fudan University (formerly Shanghai First Medical College) with excellent grades in 1956. Then he worked at Zhongnan Tongji Medical College (now Tongji Medical College of Huazhong University of Science and Technology) and its affiliated Wuhan Tongji Hospital. He soon became the backbone of the college and was responsible for establishing the Department of Pediatrics. With the aspiration of being “a good physician, a good teacher, and a good scholar”, Professor Dong strived to be progressive and comprehensive in clinical practice, teaching, and scientific research. He had devoted his whole life to safeguarding children’s health, developing pediatrics, and cultivating excellent pediatricians in China.
1956年以优异成绩毕业于复旦大学医学院(原上海第一医学院)。先后在中南同济医学院(现华中科技大学同济医学院)及其附属武汉同济医院工作。他很快成为学院的骨干,并负责建立儿科。董教授立志做“好医生、好老师、好学者”,在临床、教学、科研等方面力求全面进步。他一生致力于维护儿童健康,发展儿科学,培养中国优秀的儿科医生。
{"title":"A great pediatrician and scholar devoting his whole life to pediatric infectious and digestive diseases—In memoriam of Professor Yongsui Dong","authors":"Xinglou Liu, S. Shu, S. Gong, Xiaoping Luo, F. Fang","doi":"10.1002/ped4.12373","DOIUrl":"https://doi.org/10.1002/ped4.12373","url":null,"abstract":"Professor Dong graduated from the Medical College of Fudan University (formerly Shanghai First Medical College) with excellent grades in 1956. Then he worked at Zhongnan Tongji Medical College (now Tongji Medical College of Huazhong University of Science and Technology) and its affiliated Wuhan Tongji Hospital. He soon became the backbone of the college and was responsible for establishing the Department of Pediatrics. With the aspiration of being “a good physician, a good teacher, and a good scholar”, Professor Dong strived to be progressive and comprehensive in clinical practice, teaching, and scientific research. He had devoted his whole life to safeguarding children’s health, developing pediatrics, and cultivating excellent pediatricians in China.","PeriodicalId":19992,"journal":{"name":"Pediatric Investigation","volume":"24 1","pages":"150 - 152"},"PeriodicalIF":2.2,"publicationDate":"2023-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78987688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Pediatric Investigation
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1